News 07 aoû 2023 Longevity start-up EPITERNA raises EUR 10 million to slow ageing and extend lifespan Vaud-based longevity start-up EPITERNA has secured EUR 10 million in funding from Prima Materia, an investment firm founded by Spotify founder Da...
News 23 aoû 2023 Sion’s Pôle Santé takes shape with the laying of the first stone Valued at CHF 86 million, the Pôle Santé campus aims to be a platform for the exchange of knowledge, experience and opportunities in the healthca...
News 29 fév 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Aktuell 06 fév 2024 QUMEA erhält Investition von 9 Millionen Franken QUMEA hat in einer überzeichneten Serie-A-Finanzierungsrunde 9 Millionen Franken eingenommen. Mit dem frischen Kapital will das Digital Health-Un...
News 14 nov 2023 Opening of the Dynamic Imaging Center at sitem-insel in Bern sitem-insel has inaugurated the Dynamic Imaging Center, a groundbreaking facility that introduces a novel approach to X-ray imaging.
News 03 nov 2023 A new gel offers targeted relief for ulcerative colitis patients Researchers at the University of Bern have developed a lipid gel for direct, localized treatment of ulcerative colitis, aiming to reduce side eff...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 16 oct 2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...
News 24 mai 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Aktuell 09 jan 2024 Molecular Partners und Orano Med kooperieren Molecular Partners und Orano Med werden in der Entwicklung von Proteinmedikamenten, sogenannten DARPin-Therapeutika, zusammenarbeiten. Deren radi...
News 05 juil 2022 CHF 178 million to further develop life sciences in the canton of Vaud To consolidate the development of life sciences in the canton of Vaud, the State Council has announced an investment of CHF 178.71 million in the...
News 30 jan 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
Actualités 17 oct 2023 Voltiris, Limula et Parithera bénéficient du Start-Up Fund du Biopôle Les start-up vaudoises Voltiris, Limula et Parithera accélèrent le développement de leurs projets innovants grâce à un soutien et un financement ...
Actualités 03 nov 2023 Un nouveau gel offre un soulagement ciblé aux patients atteints de colite ulcéreuse Des chercheurs de l’Université de Berne ont mis au point un gel lipidique pour le traitement direct et localisé de la colite ulcéreuse, dans le b...
Aktuell 29 aoû 2023 Akina erhält ISO-Zertifizierung für sein Medizinprodukt Das Medtech-Start-up Akina ist für sein Qualitätsmanagement nach ISO 13485 zertifiziert worden. Damit entspricht dessen medizinische und auf Küns...
News 21 aoû 2023 Inselspital’s CHF 670 million Anna-Seiler-Haus to set new standards in healthcare On 17 August 2023, the canton of Bern celebrated a new chapter in healthcare advancement with the inauguration of the Anna-Seiler-Haus, the new m...
Actualités 14 aoû 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
News 09 jan 2024 Molecular Partners and Orano Med announce strategic partnership Molecular Partners and Orano Med are joining forces for the development of protein drugs known as DARPin therapeutics. The radioactive payloads o...